Nanospectra Biosciences, Inc.
Medical Devices & Tech
8285 El Rio Street, Suite 150
Houston, TX 77054 USA
phone: (713) 842-2720
fax: (713) 440-9349
Symbol Private
Founded 0
Employees
www.nanospectra.com/
Research Sector Medical Devices & Tech
Summary Description
Cancer therapeutics to selectively destroy tumors with minimal damage to surrounding tissue.
Management
J. Donald Payne, President
Keywords
cancer, advamed, tumor, advamed, j2008, tumor, nanoparticle, nanotechnology, auroshell, nanoshell, infrared laser, breast cancer, Texas

Comment | Printable Version | Feb. 29, 2008
If you work for Nanospectra Biosciences, Inc. and want to update this profile, click here


Description
Nanospectra Biosciences, Inc. is commercializing a particle-based therapy for the selective and precise thermal destruction of solid tumors with minimal damage to adjacent healthy tissue.
Products / Services
AuroLase Therapy combines the unique physical and optical properties of AuroShell particles with a near infrared laser source to thermally destroy cancer cells without significant damage to surrounding tissue. These particles are injected intravenously and they collect in the tumor through the associated leaky vasculature (the Enhanced Permeability and Retention effect, or EPR). Once the particles accumulate in a tumor, the area is illuminated with a near-infrared laser at wavelengths chosen to allow the maximum penetration of light through tissue. Unlike other materials, AuroShell particles are designed to specifically absorb this wavelength, and they convert the laser light into heat which results in rapid destruction of the tumor along its irregular boundaries.
Technology / Differentiation
The company utilizes a new class of microparticles to selectively destroy solid tumors. These AuroShell microparticles (also known as nanoshells) are delivered to the tumor and then activated by a near-infrared laser, resulting in the thermal destruction of the tumor and its blood vessels without significant damage to healthy tissue.
Status
Preclinical studies have shown that this therapy is highly effective.


2008-10-10-307